These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20484223)

  • 1. Inactivation of Palb2 gene leads to mesoderm differentiation defect and early embryonic lethality in mice.
    Rantakari P; Nikkilä J; Jokela H; Ola R; Pylkäs K; Lagerbohm H; Sainio K; Poutanen M; Winqvist R
    Hum Mol Genet; 2010 Aug; 19(15):3021-9. PubMed ID: 20484223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression.
    Bouwman P; Drost R; Klijn C; Pieterse M; van der Gulden H; Song JY; Szuhai K; Jonkers J
    J Pathol; 2011 May; 224(1):10-21. PubMed ID: 21404276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation.
    Hakem R; de la Pompa JL; Elia A; Potter J; Mak TW
    Nat Genet; 1997 Jul; 16(3):298-302. PubMed ID: 9207798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.
    García MJ; Fernández V; Osorio A; Barroso A; Llort G; Lázaro C; Blanco I; Caldés T; de la Hoya M; Ramón Y Cajal T; Alonso C; Tejada MI; San Román C; Robles-Díaz L; Urioste M; Benítez J
    Breast Cancer Res Treat; 2009 Feb; 113(3):545-51. PubMed ID: 18302019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
    Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
    Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recurrent mutation in PALB2 in Finnish cancer families.
    Erkko H; Xia B; Nikkilä J; Schleutker J; Syrjäkoski K; Mannermaa A; Kallioniemi A; Pylkäs K; Karppinen SM; Rapakko K; Miron A; Sheng Q; Li G; Mattila H; Bell DW; Haber DA; Grip M; Reiman M; Jukkola-Vuorinen A; Mustonen A; Kere J; Aaltonen LA; Kosma VM; Kataja V; Soini Y; Drapkin RI; Livingston DM; Winqvist R
    Nature; 2007 Mar; 446(7133):316-9. PubMed ID: 17287723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues.
    Rajan JV; Marquis ST; Gardner HP; Chodosh LA
    Dev Biol; 1997 Apr; 184(2):385-401. PubMed ID: 9133444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development.
    Gangloff YG; Mueller M; Dann SG; Svoboda P; Sticker M; Spetz JF; Um SH; Brown EJ; Cereghini S; Thomas G; Kozma SC
    Mol Cell Biol; 2004 Nov; 24(21):9508-16. PubMed ID: 15485918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells.
    Savatier P; Lapillonne H; van Grunsven LA; Rudkin BB; Samarut J
    Oncogene; 1996 Jan; 12(2):309-22. PubMed ID: 8570208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype.
    Heikkinen T; Kärkkäinen H; Aaltonen K; Milne RL; Heikkilä P; Aittomäki K; Blomqvist C; Nevanlinna H
    Clin Cancer Res; 2009 May; 15(9):3214-22. PubMed ID: 19383810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2009 Apr; 114(3):457-62. PubMed ID: 18446436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development.
    Durkin ME; Avner MR; Huh CG; Yuan BZ; Thorgeirsson SS; Popescu NC
    FEBS Lett; 2005 Feb; 579(5):1191-6. PubMed ID: 15710412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural crest and mesoderm lineage-dependent gene expression in orofacial development.
    Bhattacherjee V; Mukhopadhyay P; Singh S; Johnson C; Philipose JT; Warner CP; Greene RM; Pisano MM
    Differentiation; 2007 Jun; 75(5):463-77. PubMed ID: 17286603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brca2 is required for embryonic cellular proliferation in the mouse.
    Suzuki A; de la Pompa JL; Hakem R; Elia A; Yoshida R; Mo R; Nishina H; Chuang T; Wakeham A; Itie A; Koo W; Billia P; Ho A; Fukumoto M; Hui CC; Mak TW
    Genes Dev; 1997 May; 11(10):1242-52. PubMed ID: 9171369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compensatory functions and interdependency of the DNA-binding domain of BRCA2 with the BRCA1-PALB2-BRCA2 complex.
    Al Abo M; Dejsuphong D; Hirota K; Yonetani Y; Yamazoe M; Kurumizaka H; Takeda S
    Cancer Res; 2014 Feb; 74(3):797-807. PubMed ID: 24285729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brca1 inactivation induces p27(Kip1)-dependent cell cycle arrest and delayed development in the mouse mammary gland.
    Deans AJ; Simpson KJ; Trivett MK; Brown MA; McArthur GA
    Oncogene; 2004 Aug; 23(36):6136-45. PubMed ID: 15208652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early embryonic death in mice lacking the beta-catenin-binding protein Duplin.
    Nishiyama M; Nakayama K; Tsunematsu R; Tsukiyama T; Kikuchi A; Nakayama KI
    Mol Cell Biol; 2004 Oct; 24(19):8386-94. PubMed ID: 15367660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation.
    Connor F; Bertwistle D; Mee PJ; Ross GM; Swift S; Grigorieva E; Tybulewicz VL; Ashworth A
    Nat Genet; 1997 Dec; 17(4):423-30. PubMed ID: 9398843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wtap is required for differentiation of endoderm and mesoderm in the mouse embryo.
    Fukusumi Y; Naruse C; Asano M
    Dev Dyn; 2008 Mar; 237(3):618-29. PubMed ID: 18224709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canonical Wnt signaling is required for development of embryonic stem cell-derived mesoderm.
    Lindsley RC; Gill JG; Kyba M; Murphy TL; Murphy KM
    Development; 2006 Oct; 133(19):3787-96. PubMed ID: 16943279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.